MNTA insider filings
MOMENTA PHARMACEUTICALS INC — 29 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2020-10-01. Screen MNTA transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for MNTA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — MOMENTA PHARMACEUTICALS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2020-10-01 | 4 | Stoner Elizabeth — Director | Disposition to issuer (D): 35,509 · Disposition to issuer (D): 17,750 (derivative) · Disposition to issuer (D): 17,750 (derivative) · Disposition to issuer (D): 17,750 (derivative) · Disposition to issuer (D): 17,750 (derivative) · Disposition to issuer (D): 11,000 (derivative) · +4 more | EDGAR |
| 2020-10-01 | 4 | Gutierrez-Ramos Jose-Carlos — Director | Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 11,207 (derivative) · Disposition to issuer (D): 8,855 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2020-10-01 | 4 | GROGAN DONNA ROY — Director | Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2020-10-01 | 4 | GILMAN STEVEN C — Director | Disposition to issuer (D): 7,796 · Disposition to issuer (D): 11,207 (derivative) · Disposition to issuer (D): 8,855 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2020-10-01 | 4 | GEMAYEL GEORGES — Director | Disposition to issuer (D): 14,090 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 11,207 (derivative) · Disposition to issuer (D): 8,855 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2020-10-01 | 4 | DOWNEY BRUCE — Director | Disposition to issuer (D): 41,844 · Disposition to issuer (D): 17,750 (derivative) · Disposition to issuer (D): 17,750 (derivative) · Disposition to issuer (D): 17,750 (derivative) · Disposition to issuer (D): 17,750 (derivative) · Disposition to issuer (D): 17,750 (derivative) · +5 more | EDGAR |
| 2020-10-01 | 4 | Barlow Jane F — Director | Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2020-10-01 | 4 | Manning Anthony M. — Chief Scientific Officer | Disposition to issuer (D): 12,778 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 1,500 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 13,258 (derivative) · +9 more | EDGAR |
| 2020-10-01 | 4 | KWON YOUNG — Chief Financial & Bus. Officer | Disposition to issuer (D): 160,633 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 2,819 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 3,572 (derivative) · +16 more | EDGAR |
| 2020-10-01 | 4 | FIER IAN — Chief Mfg and Program Officer | Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 1,425 (derivative) · Disposition to issuer (D): 21,938 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 2,751 (derivative) · Disposition to issuer (D): 20,192 (derivative) · +4 more | EDGAR |
| 2020-10-01 | 4 | Cieplinska Agnieszka — Chief Accounting Officer (PAO) | Disposition to issuer (D): 8,136 · Disposition to issuer (D): 9,450 (derivative) · Disposition to issuer (D): 8,193 (derivative) · Disposition to issuer (D): 22,845 (derivative) · Disposition to issuer (D): 3,641 (derivative) · Disposition to issuer (D): 2,155 (derivative) · +1 more | EDGAR |
| 2020-10-01 | 4 | Carvajal Alejandra — Chief Legal Officer | Disposition to issuer (D): 28,795 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 21,938 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 23,188 (derivative) · Disposition to issuer (D): 13,586 (derivative) · +4 more | EDGAR |
| 2020-10-01 | 4 | BELTRAMELLO JO ANN — Chief HR and Inf. Officer | Disposition to issuer (D): 57,157 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 2,691 (derivative) · Disposition to issuer (D): 21,938 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 10,888 (derivative) · +8 more | EDGAR |
| 2020-10-01 | 4 | Arroyo Santiago — SVP, Chief Medical Officer | Disposition to issuer (D): 26 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 31,500 (derivative) · Disposition to issuer (D): 52,500 (derivative) · Disposition to issuer (D): 23,252 (derivative) · Disposition to issuer (D): 15,674 (derivative) · +4 more | EDGAR |
| 2020-10-01 | 4 | WHEELER CRAIG A — President & CEO, Director | Gift (G): 190,476 @ $0 · Disposition to issuer (D): 8,739 · Disposition to issuer (D): 36,725 · Disposition to issuer (D): 48,263 · Disposition to issuer (D): 389,120 · Disposition to issuer (D): 11,563 (derivative) · +21 more | EDGAR |
| 2020-08-21 | 4 | FIER IAN — Chief Mfg and Program Officer | Option exercise (M): 1,425 @ $18.85 · Sale (S): 1,425 @ $52.17 · Sale (S): 383 @ $52.17 · Option exercise (M): 1,425 (derivative) @ $0 | EDGAR |
| 2020-08-20 | 4 | Gutierrez-Ramos Jose-Carlos — Director | Option exercise (M): 10,000 @ $8.59 · Sale (S): 10,000 @ $52.09 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2020-08-13 | 4 | Manning Anthony M. — Chief Scientific Officer | Sale (S): 40 @ $29.34 · Sale (S): 363 @ $29.31 | EDGAR |
| 2020-08-13 | 4 | BELTRAMELLO JO ANN — Chief HR and Inf. Officer | Option exercise (M): 6,250 @ $12.76 · Sale (S): 6,250 @ $28.03 · Sale (S): 673 @ $27.88 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2020-08-13 | 4 | WHEELER CRAIG A — President & CEO, Director | Option exercise (M): 6,171 · Sale (S): 2,777 @ $28.55 · Option exercise (M): 6,171 (derivative) @ $0 | EDGAR |
| 2020-08-11 | 4 | Manning Anthony M. — Chief Scientific Officer | Option exercise (M): 750 · Sale (S): 347 @ $32.36 · Option exercise (M): 750 (derivative) @ $0 | EDGAR |
| 2020-08-11 | 4 | KWON YOUNG — Chief Financial & Bus. Officer | Option exercise (M): 1,410 · Sale (S): 652 @ $32.36 · Option exercise (M): 1,410 (derivative) @ $0 | EDGAR |
| 2020-08-11 | 4 | FIER IAN — Chief Mfg and Program Officer | Option exercise (M): 713 · Sale (S): 330 @ $32.36 · Option exercise (M): 713 (derivative) @ $0 | EDGAR |
| 2020-08-11 | 4 | BELTRAMELLO JO ANN — Chief HR and Inf. Officer | Option exercise (M): 2,690 @ $18.85 · Option exercise (M): 1,346 · Sale (S): 2,690 @ $32 · Sale (S): 622 @ $32.36 · Option exercise (M): 1,326 (derivative) @ $0 · Option exercise (M): 1,364 (derivative) @ $0 · +1 more | EDGAR |
| 2020-08-11 | 4 | WHEELER CRAIG A — President & CEO, Director | Option exercise (M): 5,781 · Sale (S): 2,601 @ $31.21 · Option exercise (M): 5,781 (derivative) @ $0 | EDGAR |
| 2020-08-07 | 4 | GILMAN STEVEN C — Director | Option exercise (M): 13,000 @ $10.63 · Sale (S): 13,000 @ $32.75 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
| 2020-08-07 | 4 | GEMAYEL GEORGES — Director | Option exercise (M): 10,000 @ $14.84 · Sale (S): 10,000 @ $33 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2020-08-06 | 4 | Arroyo Santiago — SVP, Chief Medical Officer | Option exercise (M): 10,156 @ $12.76 · Option exercise (M): 22,500 @ $17.20 · Sale (S): 34,542 @ $32.25 · Sale (S): 94 @ $32.65 · Option exercise (M): 10,156 (derivative) @ $0 · Option exercise (M): 22,500 (derivative) @ $0 | EDGAR |
| 2020-08-06 | 4 | FIER IAN — Chief Mfg and Program Officer | Option exercise (M): 24,969 @ $12.76 · Sale (S): 24,969 @ $32.76 · Option exercise (M): 24,969 (derivative) @ $0 | EDGAR |
Recent 8-K events — MOMENTA PHARMACEUTICALS INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2020-10-01 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-08-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MNTA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs